Sponsor:
Icahn School of Medicine at Mount Sinai
Code:
NCT05172921
Conditions
Thyroid Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Thyroid Cancer
Study ID
NCT05172921
Start date
Feb 3, 2022
Status verified date
Jun, 2026
Completion date
Jun, 2035
Anticipated
Primary completion date
Jun, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
500 participants
Anticipated
Arms
Exposed
Non-exposed
Primary outcome measure
Central contacts
Locations
Icahn School of Medicine at Mount Sinai
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Maaike van Gerwen
Sponsor
Icahn School of Medicine at Mount Sinai
Last update posted
Jun 17, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-26. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-06-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.